Latest filing published 18 Nov 2013 for Anacor Pharmaceuticals, Inc..
Insider track record
No signal scores available.
RHO Ventures IV LP: trading record in brief
This profile gathers the share dealings of RHO Ventures IV LP across 3 companies, led by Vanda Pharmaceuticals Inc., Anacor Pharmaceuticals, Inc. and IntraLinks Holdings, Inc. We count 10 filings; the first trade dates from 18 April 2006 and the latest from 14 November 2013.
The open-market record consists of 3 sales worth €6.4M, with no purchase.
On 18 November 2013 came the latest disclosure, a transaction in Anacor Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to RHO Ventures IV LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 303,531 shares0Common StockSEC:0001179110-13-016696:0
- 323,716 shares0Common StockSEC:0001179110-13-016439:0
- 500,000 shares@ US$14.962Common StockSEC:0001179110-06-022017:0
- 40,000 shares@ US$15.2309Common StockSEC:0001179110-06-022017:1
- 13,474 sharesCommon StockSEC:0001179110-06-021286:0
- 13,474 shares@ US$11.7874Common StockSEC:0001179110-06-021286:1
- 708,258 sharesCommon StockSEC:0001209191-06-024453:2
- 655,485 sharesCommon StockSEC:0001209191-06-024453:3
- 738,108 sharesCommon StockSEC:0001209191-06-024453:1
- 300,841 sharesCommon StockSEC:0001209191-06-024453:0
10 of 10 declarations
